In terms of Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, GlaxoSmithKline Pharmaceuticals has informed that the Board of Directors have jointly authorized the following personnel of the Company, for the purpose of determining the materiality of any event or transaction for the purpose of making disclosures to the Stock Exchange. 1. Bhushan Akshikar Managing Director. Email: - bhushan.2.akshikar@gsk.com. 2. Ronojit Biswas Whole- time Director & Chief Financial Officer: - Email:- ronojit.b.biswas@gsk.com. 3. Ajay Nadkarni Company Secretary Email: ajay.a.nadkarni@gsk.com. 4. Amit Pandey Head of Legal Email:- amit.g.pandey@gsk.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: